Pasithea Therapeutics Corp. (KTTA)
NASDAQ: KTTA · Real-Time Price · USD
0.7250
-0.0367 (-4.82%)
Feb 6, 2026, 4:00 PM EST - Market closed
Pasithea Therapeutics Analyst Ratings
Total Analysts
1
Consensus Rating
Strong Buy
Price Target
$3.00
Upside
+313.79%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates $3 | Strong Buy | Initiates | $3 | +313.79% | Dec 8, 2025 |
| EF Hutton | EF Hutton | Strong Buy Reiterates $40 | Strong Buy | Reiterates | $40 | +5,417.24% | Jul 10, 2023 |
| EF Hutton | EF Hutton | Strong Buy Initiates $40 | Strong Buy | Initiates | $40 | +5,417.24% | Jun 1, 2023 |
| EF Hutton | EF Hutton | Strong Buy Maintains $46 → $40 | Strong Buy | Maintains | $46 → $40 | +5,417.24% | Apr 3, 2023 |
| EF Hutton | EF Hutton | Strong Buy Initiates $65 | Strong Buy | Initiates | $65 | +8,865.52% | Dec 14, 2021 |